Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICL670 in Chinese aplastic anemia patients with transfusional iron overload
CTR20132500Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deferasirox in aplastic anemia, Transfusional Siderosis, sponsored by Novartis. Started Sep 2014; status: completed.
02
Drugs
deferasirox
03
Conditions
aplastic anemiaTransfusional Siderosis
Beyond the preview
Go deeper on CTR20132500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132500.